Samsung Biologics
Incheon, South Korea
Program data pending ClinicalTrials.gov matching
· Last scored 2026-04-29
68.5
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (20)
○ EMA GMP
○ MHRA GMP
Quick Facts: Samsung Biologics
- Signal Score
- 68.5/100 (as of 2026-04-29)
- Quality Compliance
- Assessment pending
- Headquarters
- Incheon, South Korea
- Modalities
- Cell Therapy, mRNA
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Samsung Biologics
Pure-play CDMO.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesCell Therapy, mRNA
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
63.0
M&A activity detected (10 articles)
Active fundraising/financial news (10 articles)
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
M&A activity detected (10 articles)
Active fundraising/financial news (10 articles)
Capacity
74.0
Active facility expansion (9 articles)
Strong partnership activity (18 articles)
Regulatory milestones (10 articles)
Sites: Incheon, KR
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
Recent Press20 articles
Active facility expansion (9 articles)
Strong partnership activity (18 articles)
Regulatory milestones (10 articles)
Recent News 20 articles
Samsung Biologics labor dispute drags on amid tensions over police complaint, AI plants - The Korea Times
Samsung Biologics labor dispute drags on amid tensions over police complaint, AI plants The Korea Times
Samsung Biologics Files Criminal Complaint Against Union - 조선일보
Samsung Biologics Files Criminal Complaint Against Union 조선일보
Samsung Biologics Files Complaint Amid Union Work-to-Rule - Businesskorea
Samsung Biologics Files Complaint Amid Union Work-to-Rule Businesskorea
Exclusive: Samsung Biologics Union Demands AI, Robot Introduction Approval - 조선일보
Exclusive: Samsung Biologics Union Demands AI, Robot Introduction Approval 조선일보
Samsung Biologics, union clash over strike conduct as talks with MOEL loom - CHOSUNBIZ - Chosunbiz
Samsung Biologics, union clash over strike conduct as talks with MOEL loom - CHOSUNBIZ Chosunbiz
Samsung Biologics Listed on Dow Jones Best-in-Class World Index for Fifth Consecutive Year - Morningstar
Samsung Biologics Listed on Dow Jones Best-in-Class World Index for Fifth Consecutive Year Morningstar
Samsung Biologics strike enters work-to-rule phase amid deadlocked talks - The Korea Herald
Samsung Biologics strike enters work-to-rule phase amid deadlocked talks The Korea Herald
First-ever strike at Samsung Biologics continues after talks fail - koreabiomed.com
First-ever strike at Samsung Biologics continues after talks fail koreabiomed.com
Samsung Biologics Says Strike Has Already Cost $102 Million - Finimize
Samsung Biologics Says Strike Has Already Cost $102 Million Finimize
Samsung Biologics strike halts cancer drug production, company projects ₩640 billion loss - 동아사이언스
Samsung Biologics strike halts cancer drug production, company projects ₩640 billion loss 동아사이언스
Samsung Biologics’ Strike Is Starting To Hit Production And Profits - Finimize
Samsung Biologics’ Strike Is Starting To Hit Production And Profits Finimize
CDMO Samsung Biologics estimates $102M impact stemming from ongoing union strike - Fierce Pharma
CDMO Samsung Biologics estimates $102M impact stemming from ongoing union strike Fierce Pharma
Samsung Biologics launches first full-scale strike - MSN
Samsung Biologics launches first full-scale strike MSN
Samsung Biologics strike escalates as union demands role in hiring, personnel evaluations, M&As - Korea JoongAng Daily
Samsung Biologics strike escalates as union demands role in hiring, personnel evaluations, M&As Korea JoongAng Daily
Labor Strains at Samsung Electronics, Samsung Biologics Raise Questions About Internal Cohesion - aju press
Labor Strains at Samsung Electronics, Samsung Biologics Raise Questions About Internal Cohesion aju press
Samsung Biologics union continues strike regarding wages, other issues - Korea JoongAng Daily
Samsung Biologics union continues strike regarding wages, other issues Korea JoongAng Daily
Samsung Biologics strike enters second day, losses hit 640 billion won - MSN
Samsung Biologics strike enters second day, losses hit 640 billion won MSN
Samsung Biologics Launches First Full-Scale Strike - 조선일보
Samsung Biologics Launches First Full-Scale Strike 조선일보
Samsung Biologics union launches 1st strike over pay dispute - The Korea Times
Samsung Biologics union launches 1st strike over pay dispute koreatimes.co.kr
Samsung Biologics hit by first-ever strike, faces up to $433 million in losses - aju press
UPDATE: Samsung Biologics union demands immediate talks as first-ever strike begins aju press
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Merck KGaA / MilliporeSigma (CDMO)
Darmstadt, DE · St. Louis, MO
Signal Score: 81.8
mRNA, Biologics, Cell Therapy
Danaher (CGT Portfolio)
Washington, DC
Signal Score: 81.5
Cell Therapy, AAV, mRNA
Lonza
Basel, Switzerland
Signal Score: 78.2
AAV, Lentiviral, Cell Therapy, mRNA
CCRM
Toronto, ON
Signal Score: 78.1
Cell Therapy, mRNA
Cytiva (Mfg Services)
Marlborough, MA · Uppsala, SE
Signal Score: 74.0
Cell Therapy, AAV, mRNA